A synthetic peptide that inhibits Granzyme B.
MorePeptide sequence shown to be preferred recognition motif for the serine protease granzyme B. Fluorogenic substrate.
MoreILK-IN-1 is a novel ILK inhibitor with IC50 of 0.6 μM.
MoreCX-3543 is a fluoroquinolone derivative with antineoplastic activity. Quarfloxin disrupts the interaction between the nucleolin protein and a G-quadruplex DNA structure in the ribosomal DNA (rDNA) template, a critical interaction for rRNA biogenesis that is overexpressed in cancer cells; disruption of this G-quadruplex DNA:protein interaction in aberrant rRNA biogenesis may result in the inhibition of ribosome synthesis and tumor cell apoptosis.
MoreFPS-ZM1 is a blood-brain-barrier permeant, non-toxic, tertiary amide compound which is a high affinity RAGE-specific inhibitor, blocking Aβ binding to the V domain of RAGE.
MoreA synthetic peptide that inhibits Granzyme B.
MorePeptide sequence shown to be preferred recognition motif for the serine protease granzyme B. Fluorogenic substrate.
MoreILK-IN-1 is a novel ILK inhibitor with IC50 of 0.6 μM.
MoreCX-3543 is a fluoroquinolone derivative with antineoplastic activity. Quarfloxin disrupts the interaction between the nucleolin protein and a G-quadruplex DNA structure in the ribosomal DNA (rDNA) template, a critical interaction for rRNA biogenesis that is overexpressed in cancer cells; disruption of this G-quadruplex DNA:protein interaction in aberrant rRNA biogenesis may result in the inhibition of ribosome synthesis and tumor cell apoptosis.
MoreFPS-ZM1 is a blood-brain-barrier permeant, non-toxic, tertiary amide compound which is a high affinity RAGE-specific inhibitor, blocking Aβ binding to the V domain of RAGE.
More